We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$6.59B
Cap. Flow %
2.29%
Top 10 Hldgs %
12.98%
Holding
8,864
New
808
Increased
4,306
Reduced
2,684
Closed
688

Sector Composition

Rank Sector Weight
1 Technology 9.82%
2 Financials 7.38%
3 Healthcare 6.65%
4 Consumer Discretionary 5.46%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
URGN icon
4501
UroGen Pharma
URGN
$2.3B
$730K ﹤0.01%
21,860
+7,866
+56% +$215K
PNTG icon
4502
Pennant Group
PNTG
$1.33B
$729K ﹤0.01%
+22,067
New +$505K
RXI icon
4503
iShares Global Consumer Discretionary ETF
RXI
$277M
$728K ﹤0.01%
5,782
-859
-13% -$105K
IPFF
4504
DELISTED
iShares International Preferred Stock ETF
IPFF
$727K ﹤0.01%
47,103
-793
-2% -$11.9K
CHUY
4505
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
$726K ﹤0.01%
28,013
+10,674
+62% +$277K
GER
4506
DELISTED
Goldman Sachs MLP Energy Renaissance Fund
GER
$726K ﹤0.01%
18,760
-54,203
-74% -$2.15M
CNCE
4507
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$726K ﹤0.01%
78,629
-3,279
-4% -$23.2K
PENG
4508
Penguin Solutions Inc
PENG
$2.94B
$725K ﹤0.01%
38,194
+12,968
+51% +$201K
GTHX
4509
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$725K ﹤0.01%
27,410
-39,261
-59% -$918K
AMC icon
4510
PUT
AMC Entertainment Holdings
AMC
$2.14B
$724K ﹤0.01%
+10,000
New +$880K
COR icon
4511
CALL
Cencora
COR
$63.7B
$723K ﹤0.01%
+8,500
New +$728K
FBM
4512
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
$721K ﹤0.01%
37,246
+21,507
+137% +$413K
CYRX icon
4513
CryoPort
CYRX
$757M
$720K ﹤0.01%
43,734
+20,021
+84% +$298K
IWL icon
4514
iShares Russell Top 200 ETF
IWL
$2.27B
$720K ﹤0.01%
9,589
-250
-3% -$17.9K
RYAM icon
4515
Rayonier Advanced Materials
RYAM
$590M
$720K ﹤0.01%
187,482
-7,363
-4% -$30.1K
MUS
4516
DELISTED
BLACKROCK MUNIHOLDINGS QUALITY FUND, INC.
MUS
$719K ﹤0.01%
57,168
-992
-2% -$12.4K
DCO icon
4517
Ducommun
DCO
$2.98B
$718K ﹤0.01%
14,204
+3,354
+31% +$154K
FGM icon
4518
First Trust Germany AlphaDEX Fund
FGM
$98.2M
$718K ﹤0.01%
16,162
+7,748
+92% +$329K
NXC
4519
DELISTED
Nuveen CA Select Tax-Free Income Portfolio
NXC
$715K ﹤0.01%
43,060
+32,060
+291% +$504K
ONDK
4520
DELISTED
On Deck Capital, Inc.
ONDK
$715K ﹤0.01%
172,709
+22,352
+15% +$89.8K
CPS icon
4521
Cooper-Standard Automotive
CPS
$487M
$714K ﹤0.01%
21,511
+12,749
+146% +$413K
ALTA
4522
DELISTED
Altabancorp
ALTA
$713K ﹤0.01%
23,689
+6,810
+40% +$200K
HEEM icon
4523
iShares Currency Hedged MSCI Emerging Markets
HEEM
$287M
$712K ﹤0.01%
26,908
+1,390
+5% +$35.7K
NC icon
4524
NACCO Industries
NC
$306M
$712K ﹤0.01%
15,202
+1,411
+10% +$74.9K
ACH
4525
Accendra Health
ACH
$96.5M
$711K ﹤0.01%
137,421
+54,435
+66% +$350K

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 808 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.